Colesevelam hydrochloride
Brand names: Cholestagel
Colesevelam is a bile-acid sequestrant used as an adjunct in the management of primary hypercholesterolaemia, often alongside a statin.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It binds bile acids in the intestine to prevent their reabsorption, increasing hepatic conversion of cholesterol to bile acids and upregulating LDL-receptor activity to lower LDL-cholesterol.
Prescribing in practice
- Because it can bind other drugs in the gut and reduce their absorption, separate the administration of interacting medicines, such as some thyroid hormones and certain anticoagulants, as advised in the SPC.
- It may raise serum triglycerides, so use with caution in patients with hypertriglyceridaemia.
- Gastrointestinal effects such as constipation are common and it can reduce absorption of fat-soluble vitamins with prolonged use.
Monitoring
Monitor the lipid profile including triglycerides to confirm response and detect any rise in triglycerides.
Counselling the patient
- Take other medicines at a separate time from this one, as advised.
- Take it with a meal and plenty of fluid.
- Report troublesome constipation so it can be managed.
Evidence & guidelines
Bile-acid sequestrants lower LDL-cholesterol and are positioned by NICE as add-on therapy when statins are insufficient or not tolerated.
Reference: Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines